An average trading volume for Vallon Pharmaceuticals Inc. (VLON) has been steady over the recent period.

After finishing at $0.24 in the prior trading day, Vallon Pharmaceuticals Inc. (NASDAQ: VLON) closed at $0.25, up 5.93%. In other words, the price has increased by $+0.0142 from its previous closing price. On the day, 220620 shares were traded. VLON stock price reached its highest trading level at $0.2850 during the session, while it also had its lowest trading level at $0.2301.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



Our goal is to gain a better understanding of VLON by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Stock Price History:

Over the past 52 weeks, VLON has reached a high of $8.54, while it has fallen to a 52-week low of $0.21. The 50-Day Moving Average of the stock is 0.2998, while the 200-Day Moving Average is calculated to be 1.4843.

Shares Statistics:

The stock has traded on average 338.31K shares per day over the past 3-months and 134.41k shares per day over the last 10 days, according to various share statistics. A total of 12.11M shares are outstanding, with a floating share count of 6.96M. Insiders hold about 0.30% of the company’s shares, while institutions hold 18.00% stake in the company. Shares short for VLON as of Oct 13, 2022 were 142.62k with a Short Ratio of 0.05M, compared to 130.77k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.36% and a Short% of Float of 2.58%.

Earnings Estimates

Its stock is currently analyzed by 0 different market analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.